{"brief_title": "Treatment Program for Anemia in AIDS Patients", "brief_summary": "The objective of the Eprex (erythropoietin) Treatment Program is to provide erythropoietin for the treatment of anemia in AIDS patients.", "condition": "Cytopenias", "intervention_type": "Drug", "intervention_name": "Epoetin alfa", "criteria": "Exclusion Criteria Co-existing Condition: Patients with the following are excluded: - Life expectancy < 3 months. - = or < grade 4 performance score. - AIDS-related dementia. - Uncontrolled hypertension. - Acute symptomatic opportunistic infection or other AIDS-defining illness. Patients with the following are excluded: - Life expectancy < 3 months. - = or < grade 4 performance score. - AIDS-related dementia. - Uncontrolled hypertension. - Acute symptomatic opportunistic infection or other AIDS-defining illness. Patients must have: - A clinical diagnosis of AIDS. - Hematocrit < 30 percent. - Endogenous serum erythropoietin level = or < 500 U/ml. - A life expectancy = or > 3 months. - > Grade 4 performance score.", "gender": "All", "minimum_age": "12 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00002022.xml"}